Innovation

Responsibility

Leadership

Swiss drugmaker Novartis resumes Ukraine business

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Swiss drugmaker Novartis resumes Ukraine business

ZURICH (Reuters) - Novartis is resuming business in Ukraine after reviewing how safe it was to operate in the country that Russia invaded in February, the Swiss drugmaker said.

FILE PHOTO: Logo is seen at new factory of Novartis in Stein

Reuters/Arnd Wiegmann FILE PHOTO: Logo is seen at new factory of Novartis in Stein

"After studying current safety protocols in the country, and on advice which we will regularly review, we have begun to resume business operations remotely to help the war-torn country restore some basic critical business processes," Novartis said on its website https://www.novartis.com/news/novartis-resumes-business-ukraine in a post dated June 1.

"The safety and security of our people remains our number one objective, and we will constantly review the situation and our business operations in Ukraine."

Novartis said it condemned the war in Ukraine and has been providing humanitarian support, financial donations and medicine to people there. Russia describes its invasion as a "special military operation" to disarm and "de-Nazify" its neighbour.

(Reporting by Paul Arnold and Michael Shields; Editing by Muralikumar Anantharaman)

Reference: Reuters: 

Ad Agency Remote

Who's On Line

We have 324 guests and no members online

Social Media Links Genius

Login Form

Recommended SEO Feeds

BBC News - Home
Cron Job Starts

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.

Ok
X

Right Click

No right click